Marco Merlano Selected Research

Marco Merlano Research Topics

Disease

27	Neoplasms (Cancer) 01/2024 - 01/2002
16	Head and Neck Neoplasms (Head and Neck Cancer) 05/2017 - 04/2003
12	Squamous Cell Carcinoma of Head and Neck 01/2024 - 05/2005
9	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2004
4	Melanoma (Melanoma, Malignant) 01/2019 - 05/2013
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2017 - 04/2002
4	Prostatic Neoplasms (Prostate Cancer) 11/2013 - 01/2006
3	Cardiotoxicity 12/2013 - 04/2011
2	Necrosis 10/2020 - 07/2007
2	Disease Progression 10/2020 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 02/2018 - 03/2014
2	Heart Failure 02/2017 - 12/2013
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2015 - 09/2014
2	Uveal melanoma 10/2013 - 02/2013
2	Stomach Neoplasms (Stomach Cancer) 11/2010 - 08/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2005 - 01/2002
2	Carcinoma (Carcinomatosis) 03/2005 - 04/2002
2	Avitaminosis (Vitamin Deficiency) 07/2003 - 01/2002
1	Sarcopenia 10/2023
1	Vascular Remodeling 06/2022
1	Sinonasal undifferentiated carcinoma 12/2021
1	Lung Diseases (Lung Disease) 12/2021
1	Neutropenia 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2018
1	Malnutrition (Nutritional Deficiencies) 10/2017
1	Anorexia 10/2017
1	Cachexia 10/2017
1	Experimental Melanoma 02/2017
1	Inflammation (Inflammations) 07/2016
1	Cardiac Tamponade 04/2016
1	Pericardial Effusion 04/2016

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2012
9	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 04/2003
8	Cetuximab (Erbitux)FDA Link 10/2023 - 10/2007
6	Docetaxel (Taxotere)FDA Link 01/2016 - 01/2006
5	ErbB Receptors (EGF Receptor)IBA 05/2017 - 02/2010
5	Hormones (Hormone)IBA 05/2016 - 01/2005
5	Fluorouracil (Carac)FDA LinkGeneric 04/2016 - 05/2005
4	PlatinumIBA 01/2024 - 07/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 02/2013
3	NivolumabIBA 01/2024 - 06/2018
3	eribulin FDA Link 06/2022 - 10/2020
3	CytokinesIBA 01/2022 - 07/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2013
3	Monoclonal AntibodiesIBA 02/2018 - 02/2013
3	Codon (Codons)IBA 05/2016 - 04/2003
3	Gemcitabine FDA Link 01/2016 - 03/2005
3	AnthracyclinesIBA 12/2013 - 04/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 11/2010
2	Interleukin-8 (Interleukin 8)IBA 10/2020 - 10/2013
2	AntibodiesIBA 02/2018 - 02/2017
2	Immunoglobulin G (IgG)IBA 02/2018 - 08/2015
2	Bevacizumab (Avastin)FDA Link 02/2017 - 02/2013
2	temsirolimus FDA Link 04/2016 - 01/2016
2	Everolimus FDA Link 05/2015 - 09/2014
2	AndrogensIBA 11/2013 - 08/2008
2	vandetanib (ZD6474)IBA 11/2013 - 08/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2005 - 05/2005
2	CarcinogensIBA 07/2003 - 01/2002
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Tramadol (K315)FDA LinkGeneric 01/2024
1	milbemycin oxime (Interceptor)IBA 10/2023
1	cadherin 5IBA 06/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	interleukin-21 (interleukin 21)IBA 10/2020
1	Interleukin-10 (Interleukin 10)IBA 10/2020
1	ChemokinesIBA 10/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	EMA400IBA 01/2019
1	2-oxoglutarate 3-dioxygenase prolineIBA 01/2019
1	PD 123319IBA 01/2019
1	CollagenIBA 01/2019
1	Losartan (Cozaar)FDA LinkGeneric 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 02/2017
1	Therapeutic UsesIBA 02/2017
1	Protein Isoforms (Isoforms)IBA 02/2017
1	Oxygen (Dioxygen)IBA 02/2017
1	VaccinesIBA 02/2017
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 02/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	NucleotidesIBA 01/2017
1	arginylprolineIBA 05/2016
1	SteroidsIBA 05/2016
1	Estrogen ReceptorsIBA 05/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2016
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2016

Therapy/Procedure

17	Radiotherapy 12/2021 - 04/2003
17	Drug Therapy (Chemotherapy) 12/2021 - 01/2002
14	Therapeutics 10/2023 - 04/2003
6	Immunotherapy 01/2024 - 01/2016
5	Chemoradiotherapy 01/2017 - 08/2003
2	Adjuvant Chemotherapy 06/2012 - 04/2011
2	TP protocol 01/2006 - 05/2005
1	Induction Chemotherapy 10/2023